GlioPharma ApS — Credit Rating and Financial Key Figures

CVR number: 37256641
Birkemose Allé 27, Nørre Bjert 6000 Kolding

Income statement (kDKK)

2016
2017
Fiscal period length1212
Net sales
Gross profit12.00-14.51
EBIT12.00-14.51
Other financial expenses-5.00-7.09
Pre-tax profit7.00-21.60
Income taxes-3.00
Net earnings4.00-21.60

Assets (kDKK)

2016
2017
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables20.000.36
Short term receivables total20.000.36
Cash and bank deposits164.00168.36
Cash and cash equivalents164.00168.36
Balance sheet total (assets)184.00168.72

Equity and liabilities (kDKK)

2016
2017
Share capital50.0050.00
Retained earnings4.42
Profit of the financial year4.00-21.60
Shareholders equity total54.0032.82
Non-current other liabilities104.00
Non-current liabilities total104.00
Current trade creditors23.0021.79
Short-term deferred tax liabilities3.002.86
Other non-interest bearing current liabilities111.25
Current liabilities total26.00135.90
Balance sheet total (liabilities)184.00168.72
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.